Dermatologists have conducted a research study that proves "smartphone microscopes" can improve the detection of skin cancer in remote areas and in developing nations, where specialists are not as easily accessible to patients.
“Smartphone microscopes” used by doctors in remote areas can potentially make it easier for specialists to assess whether a dermal patch could be malignant.
Dermatologists at the University of Texas Health Science Center at Houston (UTHealth) have conducted a research study that proves these devices can improve the detection of skin cancer in remote areas and in developing nations, where specialists are not as easily accessible to patients. The authors used the smartphone microscope to evaluate over a 1000 dermatopathology cases, prospectively and in a blinded fashion. Standard light microscopy was simultaneously used on the specimens for comparison of results. The sensitivity and specificity for the diagnosis of melanoma, nonmelanoma skin cancers, and other miscellaneous conditions by the phone microscopy platform, as compared with traditional light microscopy, were calculated.
In their paper published in the Archives of Pathology & Laboratory Medicine, the authors report that the sensitivity and specificity of smartphone microscopy were 95.6% and 98.1%, respectively, for basal cell carcinoma; 89.4% and 97.3%, respectively, for squamous cell carcinoma; and 60% and 99.1%, respectively, for melanoma.
“We did a head-to-head comparison with a traditional light microscope and while the smartphone microscope wasn't as accurate it resulted in the detection of about 90 percent of the non-melanoma skin cancers,” said Jahan-Tigh, MD, assistant professor of dermatology at John P. and Kathrine G. McGovern Medical School at UTHealth and lead author of the study, in a statement. “This is a good first step to show that smartphone microscopy has a future in dermatology and pathology,” he added.
The authors write that their results demonstrate the potential for a high-performing, low-cost smartphone microscopy system in the diagnosis of cutaneous disease and that additional studies could help improve this modality for point-of-care diagnostics in resource-poor settings. They conclude that mobile phone—based microscopy has excellent performance characteristics for the inexpensive diagnosis of nonmelanoma skin cancers in a setting where a traditional microscope is not available.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More